The end of hepatitis C.
Department of Surgery, Baylor College of Medicine, Houston, Texas.
Norman L
NL
Sussman
National Institute for Mathematical and Biological Synthesis, University of Tennessee, Knoxville, Tennessee.
Christopher H
CH
Remien
Department of Medicine, Baylor College of Medicine, Houston VA Health Services Research and Development Center of Excellence, Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.
Fasiha
F
Kanwal
D000284:Administration, Oral; D000998:Antiviral Agents / Q000627:therapeutic use*; D060740:Disease Eradication; D004359:Drug Therapy, Combination / Q000379:methods; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D014481:United States / Q000453:epidemiology
D000998:Antiviral Agents